Pirfenidone in Adult Hospitalized Patients With COVID-19
Status:
Active, not recruiting
Trial end date:
2023-03-30
Target enrollment:
Participant gender:
Summary
This center intends to conduct a multicenter, randomized, placebo-controlled study to
evaluate the effectiveness and safety of Nintedanib ethanesulfonate soft capsule in the
treatment of pulmonary fibrosis in patients with moderate to severe COVID-19.